2022
DOI: 10.1007/s11604-022-01343-5
|View full text |Cite
|
Sign up to set email alerts
|

Clinical and neuroimaging review of triplet repeat diseases

Abstract: Triplet repeat diseases (TRDs) refer to a group of diseases caused by three nucleotide repeats elongated beyond a pathologic threshold. TRDs are divided into the following four groups depending on the pathomechanisms, although the pathomechanisms of several diseases remain unelucidated: polyglutamine disorders, caused by a pathologic repeat expansion of CAG (coding the amino acid glutamine) located within the exon; loss-of-function repeat disorders, characterized by the common feature of a loss of function of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 95 publications
0
2
0
Order By: Relevance
“… 21 Trinucleotide repeat expansion analysis is not included (or covered by insurance) in the genetic workup of infantile or childhood‐onset neurodegenerative movement disorders, especially in the absence of a significant familial history and the role of polyglutamine defect is probably underrecognized. 22 Our case highlights that polyglutamine diseases should be considered, even in infantile‐onset neurodegenerative diseases without family history. However, polyQ detection raised ethical issues; delineation of the spectrum of polyglutamine defects in infants and children will be necessary meanwhile novel techniques for genome‐wide evaluation of repeat expansions are under development and validation.…”
Section: Discussionmentioning
confidence: 83%
See 1 more Smart Citation
“… 21 Trinucleotide repeat expansion analysis is not included (or covered by insurance) in the genetic workup of infantile or childhood‐onset neurodegenerative movement disorders, especially in the absence of a significant familial history and the role of polyglutamine defect is probably underrecognized. 22 Our case highlights that polyglutamine diseases should be considered, even in infantile‐onset neurodegenerative diseases without family history. However, polyQ detection raised ethical issues; delineation of the spectrum of polyglutamine defects in infants and children will be necessary meanwhile novel techniques for genome‐wide evaluation of repeat expansions are under development and validation.…”
Section: Discussionmentioning
confidence: 83%
“…Recently, a high prevalence of individuals carrying intermediate or pathological ranges of polyglutamine disease‐associated alleles among the general population has been reported 21 . Trinucleotide repeat expansion analysis is not included (or covered by insurance) in the genetic workup of infantile or childhood‐onset neurodegenerative movement disorders, especially in the absence of a significant familial history and the role of polyglutamine defect is probably underrecognized 22 . Our case highlights that polyglutamine diseases should be considered, even in infantile‐onset neurodegenerative diseases without family history.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, a rare type of primary hypophysitis predominantly affecting the female population is xanthomatous hypophysitis, histologically different from other subtypes (infiltration of foamy histiocytes) but clinically can be similar to LHy [3]. Gadolinium-enhanced magnetic resonance imaging (MRI) is very helpful and helps prevent invasive diagnosis with biopsy [4].…”
Section: Introductionmentioning
confidence: 99%